Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:03 PM
Ignite Modification Date:
2025-12-24 @ 11:03 PM
NCT ID:
NCT04067869
Eligibility Criteria:
Inclusion Criteria:
* Patients included in the Aquitaine ANRS CO3 cohort aged 18 years or older (confirmed HIV-1 infection and at least one follow-up in the cohort),
* plasma HIV-1 RNA \<50 copies / ml for at least 24 months under a highly active antiretroviral combination (treatment comprising at least 3 antiretroviral drugs) modified or initiated between 2005 and 2008,
* Follow-up in one of the departments of Bordeaux University Hospital or Libourne Hospital,
* Free, informed and written consent, signed by the patient and the investigator (Consent of the Aquitaine CO3 Cohort and linked to this specific study).
Exclusion Criteria:
* Presence of 2 consecutive measurements of HIV RNA\> 50 copies / ml,
* History of immunotherapy treatments (interleukin-2),
* Hepatitis B or C co-infections,
* Pregnancy
* Breastfeeding
* Symptomatic infectious episode in progress.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT04067869
Study Brief:
Protocol Section:
NCT04067869